FDA.report

Application 078830

Type
ANDA
Sponsor
PERRIGO PHARMS CO

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001SCOPOLAMINESCOPOLAMINEFILM, EXTENDED RELEASE;TRANSDERMAL1MG/72HRNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
45802-580Scopolamine Trandermal Systemscolopamine transdermal systemPadagis Israel Pharmaceuticals LtdANDACurrent
45802-580Scopolamine Trandermal Systemscolopamine transdermal systemPerrigo New York IncANDACurrent
45802-580Scopolamine Trandermal Systemscolopamine transdermal systemPerrigo New York IncANDACurrent
63629-8450Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent
63629-8450Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent
63629-8450Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent
63629-8451Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent
63629-8451Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent
63629-8451Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent
63629-8452Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent
63629-8452Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent
63629-8452Scopolamine Trandermal Systemscolopamine transdermal systemBryant Ranch PrepackANDACurrent

Documents

DocumentSubmission typeDate
54774ORIG2018-07-05
18488ORIG2015-02-26
9189ORIG2015-02-26